other player(s) mediate(s) the apoptotic event downstream of cytochrome c at the post-mitochondrial level. A somewhat different setting but relevant finding has been reported previously [34]. Zhou et al. investigated how Akt regulates hybrid motor neuron 1 cells, a neuronal cell line that requires PI 3-kinase/Akt for survival [34]. They found that Akt inhibits cell death and cytochrome c-induced caspase activation without blocking the release of cytochrome c, suggesting that Akt regulates the suppression of the neural apoptosis at a post-mitochondrial stage, downstream of cytochrome c release, and before activating caspase-9 [34].

Together, our data indicated that PDTC inhibited luteolin-induced apoptosis in both extrinsic and intrinsic pathways (Figure 6), potentially modulated by Akt. Further studies deem necessary to elucidate the regulatory roles of Akt in the combining effect of luteolin and PDTC between the dynamics of apoptosis and cell survival. The combination of luteolin and PDTC increased the survival of the cancer cells rather than reduced the cell number in HL-60 cells. This finding may have clinical implication that the therapeutic effect of anti-cancer medications may not be synergistic, but antagonistic, and should be monitored carefully.

Figure 6. Schematic model of the PDTC suppression effect on luteolin-induced apoptosis in HL-60 cells. PDTC may suppress luteolin-induced apoptosis by inhibiting both the death receptor pathway and the activation of Bad, Bax, and Bcl-XL.

5. Acknowledgements

This work was supported by the grants, NSC98-2320-B- 309-002-MY3 and NSC101-2320-B-309-001 to MingFen Lee and NSC100-2313-B-309-003 to An-Chin Cheng, from National Science Council (Taiwan).


  1. A. Crozier, J. Burns, A. A. Aziz, A. J. Stewart, H. S. Rabiasz, G. I. Jenkins, C. A. Edwards and M. E. Lean, “Antioxidant Flavonols from Fruits, Vegetables and Beverages: Measurements and Bioavailability,” Biological Research, Vol. 33, No. 2, 2000, pp. 79-88. doi:10.4067/S0716-97602000000200007
  2. D. F. Birt, S. Hendrich and W. Wang, “Dietary Agents in Cancer Prevention: Flavonoids and Isoflavonoids,” Pharmacology & Therapeutics, Vol. 90, No. 2-3, 2001, pp. 157-177. doi:10.1016/S0163-7258(01)00137-1
  3. C. S. Yang, J. M. Landau, M. T. Huang and H. L. Newmark, “Inhibition of Carcinogenesis by Dietary Polyphenolic Compounds,” Annual Review of Nutrition, Vol. 21, 2001, pp. 381-406. doi:10.1146/annurev.nutr.21.1.381
  4. Y. J. Surh, “Cancer Chemoprevention with Dietary Phytochemicals,” Nature Reviews Cancer, Vol. 3, No. 10, 2003, pp. 768-780. doi:10.1038/nrc1189
  5. J. A. Ross and C. M. Kasum, “Dietary Flavonoids: Bioavailability, Metabolic Effects, and Safety,” Annual Review of Nutrition, Vol. 22, 2002, pp. 19-34. doi:10.1146/annurev.nutr.22.111401.144957
  6. Y. T. Huang, J. J. Hwang, P. P. Lee, F. C. Ke, J. H. Huang, C. J. Huang, C. Kandaswami, E. Middleton Jr. and M. T. Lee, “Effects of Luteolin and Quercetin, Inhibitors of Tyrosine Kinase, on Cell Growth and Metastasis-Associated Properties in A431 Cells Overexpressing Epidermal Growth Factor Receptor,” British Journal of Pharmacology, Vol. 128, No. 5, 1999, pp. 999-1010. doi:10.1038/sj.bjp.0702879
  7. W. G. Ko, T. H. Kang, S. J. Lee, Y. C. Kim and B. H. Lee, “Effects of Luteolin on the Inhibition of Proliferation and Induction of Apoptosis in Human Myeloid Leukaemia Cells,” Phytotherapy Research, Vol. 16, No. 3, 2002, pp. 295-298. doi:10.1002/ptr.871
  8. H. W. Leung, C. H. Wu, C. H. Lin and H. Z. Lee, “Luteolin Induced DNA Damage Leading to Human Lung SquaMous Carcinoma CH27 Cell Apoptosis,” European Journal of Pharmacology, Vol. 508, No. 1-3, 2005, pp. 77-83. doi:10.1016/j.ejphar.2004.12.032
  9. R. X. Shi, C. N. Ong and H. M. Shen, “Protein Kinase C Inhibition and x-Linked Inhibitor of Apoptosis Protein Degradation Contribute to the Sensitization Effect of Luteolin on Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis in Cancer Cells,” Cancer Research, Vol. 65, No. 17, 2005, pp. 7815-7823.
  10. C. P. Xavier, C. F. Lima, A. Preto, R. Seruca, M. Fernandes-Ferreira and C. Pereira-Wilson, “Luteolin, Quercetin and Ursolic Acid Are Potent Inhibitors of Proliferation and Inducers of Apoptosis in both KRAS and BRAF Mutated Human Colorectal Cancer Cells,” Cancer Letters, Vol. 281, No. 2, 2009, pp. 162-170. doi:10.1016/j.canlet.2009.02.041
  11. A. C. Cheng, T. C. Huang, C. S. Lai and M. H. Pan, “Induction of Apoptosis by Luteolin through Cleavage of Bcl-2 Family in Human Leukemia HL-60 Cells,” European Journal of Pharmacology, Vol. 509, No. 1, 2005, pp. 1-10. doi:10.1016/j.ejphar.2004.12.026
  12. A. M. Komarov, I. T. Mak and W. B. Weglicki, “Iron Potentiates Nitric Oxide Scavenging by Dithiocarbamates in Tissue of Septic Shock Mice,” Biochimica Biophysica Acta, Vol. 1361, No. 3, 1997, pp. 229-234. doi:10.1016/S0925-4439(97)84636-4
  13. A. B. Nathens, R. Bitar, C. Davreux, M. Bujard, J. C. Marshall, A. P. Dackiw, R. W. Watson and O. D. Rotstein, “Pyrrolidine Dithiocarbamate Attenuates EndotoxinInduced Acute Lung Injury,” American Journal of Respiratory Cell and Molecular Biology, Vol. 17, No. 5, 1997, pp. 608-616.
  14. S. Verhaegen, A. J. McGowan, A. R. Brophy, R. S. Fernandes and T. G. Cotter, “Inhibition of Apoptosis by Antioxidants in the Human HL-60 Leukemia Cell Line,” Biochemical Pharmacology, Vol. 50, No. 7, 1995, pp. 1021-1029. doi:10.1016/0006-2952(95)00233-P
  15. D. Moellering, J. McAndrew, H. Jo and V. M. DarleyUsmar, “Effects of Pyrrolidine Dithiocarbamate on Endothelial Cells: Protection against Oxidative Stress,” Free Radical Biology & Medicine, Vol. 26, No. 9-10, 1999, pp. 1138-1145. doi:10.1016/S0891-5849(98)00300-1
  16. F. Di Nicuolo, S. Serini, A. Boninsegna, P. Palozza and G. Calviello, “Redox Regulation of Cell Proliferation by Pyrrolidine Dithiocarbamate in Murine Thymoma Cells Transplanted in Vivo,” Free Radical Biology & Medicine, Vol. 31, No. 11, 2001, pp. 1424-1431. doi:10.1016/S0891-5849(01)00714-6
  17. C. I. Nobel, M. Kimland, B. Lind, S. Orrenius and A. F. Slater, “Dithiocarbamates Induce Apoptosis in Thymocytes by Raising the Intracellular Level of Redox-Active Copper,” The Journal of Biological Chemistry, Vol. 270, No. 44, 1995, pp. 26202-26208. doi:10.1074/jbc.270.44.26202
  18. P. Brennan and L. A. O’Neill, “2-Mercaptoethanol Restores the Ability of Nuclear Factor Kappa B (NF Kappa B) to Bind DNA in Nuclear Extracts from Interleukin 1-Treated Cells Incubated with Pyrollidine Dithiocarbamate (PDTC). Evidence for Oxidation of Glutathione in the Mechanism of Inhibition of NF Kappa B by PDTC,” The Biochemical Journal, Vol. 320, 1996, pp. 975-981.
  19. W. Erl, C. Weber and G. K. Hansson, “Pyrrolidine Dithiocarbamate-Induced Apoptosis Depends on Cell Type, Density, and the Presence of Cu(2+) and Zn(2+),” American Journal of Physiology Cell Physiology, Vol. 278, No. 6, 2000, pp. C1116-C1125.
  20. R. Bessho, K. Matsubara, M. Kubota, K. Kuwakado, H. Hirota, Y. Wakazono, Y. W. Lin, A. Okuda, M. Kawai, R. Nishikomori, et al., “Pyrrolidine Dithiocarbamate, a Potent Inhibitor of Nuclear Factor Kappa B (NF-Kappa B) Activation, Prevents Apoptosis in Human Promyelocytic Leukemia HL-60 Cells and Thymocytes,” Biochemical Pharmacology, Vol. 48, No. 10, 1994, pp. 1883-1889. doi:10.1016/0006-2952(94)90586-X
  21. H. S. Chung, H. J. Jeong, S. H. Hong, M. S. Kim, S. J. Kim, B. K. Song, I. S. Jeong, E. J. Lee, J. W. Ahn, S. H. Baek and H. M. Kim, “Induction of Nitric Oxide Synthase by Oldenlandia Diffusa in Mouse Peritoneal Macrophages,” Biological & Pharmaceutical Bulletin, Vol. 25, No. 9, 2002, pp. 1142-1146. doi:10.1248/bpb.25.1142
  22. M. Grafe, G. Steinheider, U. Desaga, C. Warnecke, H. B. Lehmkuhl, V. Regitz-Zagrosek, A. G. Hildebrandt and E. Fleck, “Characterization of Two Distinct Mechanisms for Induction of Apoptosis in Human Vascular Endothelial Cells,” Clinical Chemistry and Laboratory Medicine, Vol. 37, No. 5, 1999, pp. 505-510. doi:10.1515/CCLM.1999.081
  23. C. C. Hu, C. H. Hsiao, S. Y. Huang, S. H. Fu, C. C. Lai, T. M. Hong, H. H. Chen and F. J. Lu, “Antioxidant Activity of Fermented Soybean Extract,” Journal of Agricultural and Food Chemistry, Vol. 52, No. 18, 2004, pp. 5735-5739. doi:10.1021/jf035075b
  24. R. Li, D. J. Bounds, D. Granville, S. H. Ip, H. Jiang, P. Margaron and D. W. Hunt, “Rapid Induction of Apoptosis in Human Keratinocytes with the Photosensitizer QLT0074 via a Direct Mitochondrial Action,” Apoptosis, Vol. 8, No. 3, 2003, pp. 269-275. doi:10.1023/A:1023624922787
  25. F. Della Ragione, V. Cucciolla, A. Borriello, V. Della Pietra, C. Manna, P. Galletti and V. Zappia, “Pyrrolidine Dithiocarbamate Induces Apoptosis by a Cytochrome c-Dependent Mechanism,” Biochemical and Biophysical Research Communications, Vol. 268, No. 3, 2000, pp. 942-946. doi:10.1006/bbrc.2000.2161
  26. J. L. Herrmann, A. W. Beham, M. Sarkiss, P. J. Chiao, M. T. Rands, E. M. Bruckheimer, S. Brisbay and T. J. McDonnell, “Bcl-2 Suppresses Apoptosis Resulting from Disruption of the NF-Kappa B Survival Pathway,” Experimental Cell Research, Vol. 237, No. 1, 1997, pp. 101- 109. doi:10.1006/excr.1997.3737
  27. J. S. Thompson, R. Asmis, A. A. Tapp, B. Nelson, Y. Chu, J. Glass, M. Moneyhon and S. A. Brown, “Pyrrolidine Dithiocarbamate (PDTC) Blocks Apoptosis and Promotes Ionizing Radiation-Induced Necrosis of FreshlyIsolated Normal Mouse Spleen Cells,” Apoptosis, Vol. 15, No. 6, 2010, pp. 705-714. doi:10.1007/s10495-010-0487-7
  28. A. C. Cheng, T. C. Huang, C. S. Lai, J. M. Kuo, Y. T. Huang, C. Y. Lo, C. T. Ho and M. H. Pan, “Pyrrolidine Dithiocarbamate Inhibition of Luteolin-Induced Apoptosis through Up-Regulated Phosphorylation of Akt and Caspase-9 in Human Leukemia HL-60 Cells,” Journal of Agricultural and Food Chemistry, Vol. 54, No. 12, 2006, pp. 4215-4221. doi:10.1021/jf060269n
  29. D. S. Bellows, B. N. Chau, P. Lee, Y. Lazebnik, W. H. Burns and J. M. Hardwick, “Antiapoptotic Herpesvirus Bcl-2 Homologs Escape Caspase-Mediated Conversion to Proapoptotic Proteins,” Journal of Virology, Vol. 74, No. 11, 2000, pp. 5024-5031. doi:10.1128/JVI.74.11.5024-5031.2000
  30. D. E. Wood, A. Thomas, L. A. Devi, Y. Berman, R. C. Beavis, J. C. Reed and E. W. Newcomb, “Bax Cleavage Is Mediated by Calpain during Drug-Induced Apoptosis,” Oncogene, Vol. 17, No. 9, 1998, pp. 1069-1078. doi:10.1038/sj.onc.1202034
  31. H. Toyota, N. Yanase, T. Yoshimoto, M. Moriyama, T. Sudo and J. Mizuguchi, “Calpain-Induced Bax-Cleavage Product Is a More Potent Inducer of Apoptotic Cell Death than Wild-Type Bax,” Cancer Letters, Vol. 189, No. 2, 2003, pp. 221-230. doi:10.1016/S0304-3835(02)00552-9
  32. S. M. Uriarte, S. Joshi-Barve, Z. Song, R. Sahoo, L. Gobejishvili, V. R. Jala, B. Haribabu, C. McClain and S. Barve, “Akt Inhibition Upregulates FasL, Downregulates c-FLIPs and Induces Caspase-8-Dependent Cell Death in Jurkat T Lymphocytes,” Cell Death and Differentiation, Vol. 12, No. 3, 2005, pp. 233-242. doi:10.1038/sj.cdd.4401549
  33. S. Garcia, M. Liz, J. J. Gomez-Reino and C. Conde, “Akt Activity Protects Rheumatoid Synovial Fibroblasts from Fas-Induced Apoptosis by Inhibition of Bid Cleavage,” Arthritis Research & Therapy, Vol. 12, No. 1, 2010, pp. R33. doi:10.1186/ar2941
  34. H. Zhou, X. M. Li, J. Meinkoth and R. N. Pittman, “Akt Regulates Cell Survival and Apoptosis at a Postmitochondrial Level,” The Journal of Cell Biology, Vol. 151, No. 3, 2000, pp. 483-494. doi:10.1083/jcb.151.3.483


*The authors declare no conflict of interest for this manuscript.

#Corresponding author.

Journal Menu >>